mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice
Abstract The emergence of SARS-CoV-2 variants with defined mutations that enhance pathogenicity or facilitate immune evasion has resulted in a continual decline in the protective efficacy of existing vaccines. Therefore, there is a pressing need for a vaccine capable of combating future variants. In...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-025-01066-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|